Drugs that cause sexual dysfunction

Psychiatry

Volumn 6, Issue 3, 2007, Pages 111-114

  Smith, Shubulade ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

anti epileptics; antidepressants; antihypertensives; antipsychotics; benzodiazepines; prostate medication; recreational drugs

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABIS; DULOXETINE; FINASTERIDE; LEVODOPA; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; REBOXETINE; RECREATIONAL DRUG; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TADALAFIL; THIAZIDE DIURETIC AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; VARDENAFIL; VENLAFAXINE; VILOXAZINE; YOHIMBINE;

ANORGASMIA; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOSE RESPONSE; DROWSINESS; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FEMALE; FEMINIZATION; HUMAN; HYPERSEXUALITY; LIBIDO; LIBIDO DISORDER; MALE; ORGASM DISORDER; PREMATURE EJACULATION; PRIAPISM; PRIORITY JOURNAL; PSYCHOSEXUAL DEVELOPMENT; REVIEW; SEX THERAPY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL;

EID: 33847217967     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mppsy.2006.12.004     Document Type: Review

References (24)

1. Mourits M.J., Bockermann I., de Vries E.G., et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br J Cancer 86 (2002) 1546-1550
2. Werneke U., Northey S., and Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand 114 (2006) 384-397
3. Montejo A.L., Llorca G., Izquierdo J.A., and Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 62 Suppl 3 (2001) 10-21
4. Bonierbale M., Lancon C., and Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 19 (2003) 114-124
5. Clayton A.H., Pradko J.F., Croft H.A., et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63 (2002) 357-366
6. Gregorian R.S., Golden K.A., Bahce A., Goodman C., Kwong W.J., and Khan Z.M. Antidepressant-induced sexual dysfunction. Ann Pharmacother 36 (2002) 1577-1589
7. Manasia P., Pomerol J., Ribe N., Gutierrez del Pozo R., and Alcover Garcia J. Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation. J Urol 170 (2003) 164-165
8. Kennedy S.H., Eisfeld B.S., Dickens S.E., Bacchiochi J.R., and Bagby R.M. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 61 (2000) 276-281
9. Clayton A.H., Zajecka J., Ferguson J.M., Filipiak-Reisner J.K., Brown M.T., and Schwartz G.E. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 18 (2003) 151-156
10. Saiz-Ruiz J., Montes J.M., Ibanez A., et al. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. Hum Psychopharmacol 20 (2005) 435-440
11. Meinhardt W., Schmitz P.I., Kropman R.F., et al. Trazodone, a double blind trial for treatment of erectile dysfunction. Int J Impot Res 9 (1997) 163-165
12. Delgado P.L., Brannan S.K., Mallinckrodt C.H., et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66 (2005) 686-692
13. Lambert M.V. Seizures, hormones and sexuality. Seizure 10 (2001) 319-340
14. Smith S., O'Keane V., and Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181 (2002) 49-55
15. Bobes J., Garc A-Portilla M.P., Rejas J., et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 29 (2003) 125-147
16. Hummer M., Kemmler G., Kurz M., Kurzthaler I., Oberbauer H., and Fleischhacker W.W. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 156 (1999) 631-633
17. Cocores J.A., Miller N.S., Pottash A.C., and Gold M.S. Sexual dysfunction in abusers of cocaine and alcohol. Am J Drug Alcohol Abuse 14 (1988) 169-173
18. Zemishlany Z., Aizenberg D., and Weizman A. Subjective effects of MDMA ('Ecstasy') on human sexual function. Eur Psychiatry 16 (2001) 127-130
19. Passie T., Hartmann U., Schneider U., Emrich H.M., and Kruger T.H. Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion. Med Hypotheses 64 (2005) 899-903
20. Schilder A.J., Lampinen T.M., Miller M.L., and Hogg R.S. Crystal methamphetamine and ecstasy differ in relation to unsafe sex among young gay men. Can J Public Health 96 (2005) 340-343
21. Emanuele M.A., and Emanuele N.V. Alcohols effects on male reproduction. Alcohol Health Res World 22 (1998) 195-201
22. Mirin S.M., Meyer R.E., Mendelson J.H., and Ellingboe J. Opiate use and sexual function. Am J Psychiatry 137 (1980) 909-915
23. Bliesener N., Albrecht S., Schwager A., Weckbecker K., Lichtermann D., and Klingmuller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 90 (2005) 203-206
24. Palha A.P., and Esteves M. A study of the sexuality of opiate addicts. J Sex Marital Ther 28 (2002) 427-437